2 completed, 1 active not recruiting, 1 recruiting, 1 terminated. 6 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Completed 2, Active not recruiting 1, Recruiting 1, Terminated 1, Withdrawn 1 |
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow Soft Tissue Sarcoma Adult: new trials by email Literature Review of Soft Tissue Sarcoma Adult trials Research Report on Soft Tissue Sarcoma Adult
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Fluorescent Aided Resection and Evaluation of Soft Tissue Sarcomas (FLARES) Aminolevulinic Acid - Soft Tissue Sarcoma, Soft Tissue Sarcoma Adult | Phase 1 | Withdrawn | University of California, Davis | 2024-07-01 | 2024-08-15 | |
| Sarcomas and DDR-Inhibition; a Combined Modality Study AZD1390 + radiotherapy, AZD1390 + durvlaumab + radiotherapy - Soft Tissue Sarcoma Adult | Phase 1 | Terminated | The Netherlands Cancer Institute | 12 | 2022-07-18 | 2026-01-23 |
| Phase 1 Study of SON-1010 in Adult Patients With Advanced Solid Tumors SON-1010 - Advanced Solid Tumor, Soft Tissue Sarcoma Adult | Phase 1 | Active not recruiting | Sonnet BioTherapeutics | 42 | 2022-04-20 | 2026-02-03 |
| Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma Retifanlimab, Gemcitabine, Docetaxel - Soft Tissue Sarcoma, Sarcoma,Soft Tissue | Phase 1 / Phase 2 | Recruiting | Memorial Sloan Kettering Cancer Center | 98 | 2020-09-29 | 2026-09-08 |
| Lenvatinib and Eribulin in Advanced Soft Tissue Sarcoma Eribulin, Lenvatinib - Leiomyosarcoma, Liposarcoma | Phase 1 / Phase 2 | Completed | National Taiwan University Hospital | 30 | 2018-07-12 | 2025-12-05 |
| Precise Local Injection of Anti-cancer Drugs Using Presage's CIVO Device in Soft Tissue Sarcoma Multiple drug microinjection, CIVO device - Soft Tissue Sarcoma Adult | Phase 1 | Completed | Presage Biosciences | 23 | 2016-12-15 | 2021-09-24 |
Sarcoma (5) · Leiomyosarcoma (1) · Liposarcoma (1)
Neoplasms (5) · Neoplasms by Histologic Type (5) · Neoplasms, Connective and Soft Tissue (5) · Neoplasms, Adipose Tissue (1) · Neoplasms, Muscle Tissue (1)
Docetaxel (2) · Gemcitabine (2) · eribulin (2) · AZD1390 (1) · Aminolevulinic Acid (1) · Bortezomib (1) · Doxorubicin (1) · Interferon alpha-2 (1) · Interferon-gamma (1) · Ipilimumab (1) · Nivolumab (1) · Radiotherapy (1) · Sodium Chloride (1) · Trabectedin (1) · aldesleukin (1)
Memorial Sloan Kettering Cancer Center (1) · National Taiwan University Hospital (1) · Presage Biosciences (1) · Sonnet BioTherapeutics (1) · The Netherlands Cancer Institute (1) · University of California, Davis (1)
United States (4) · Netherlands (1) · Taiwan (1)
Gary Deutsch, MD (1) · Kenneth Gundle, MD (1) · Richard Kenney, MD (1) · Rick Haas, MD Prof (1) · Sandra D'Angelo, MD (1) · Seth Pollack, MD (1) · Steven W Thorpe, MD (1) · Wei-Wu Chen, MD (1)